1. ACTR-39. PAMIPARIB IN COMBINATION WITH RADIATION THERAPY (RT) AND/OR TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED OR RECURRENT/REFRACTORY (R/R) GLIOBLASTOMA (GBM); PHASE 1B/2 STUDY UPDATE. (11th November 2019) Authors: Piotrowski, Anna; Puduvalli, Vinay; Wen, Patrick; Campian, Jian; Colman, Howard; Pearlman, Michael; Butowski, Nicholas; Battiste, James; Glass, Jon; Cloughesy, Timothy; Schiff, David; van den Bent, Martin; Walbert, Tobias; Ahluwalia, Manmeet; Badruddoja, Michael; Kalra, Amandeep; Aregawi, Dawit; ... Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ACTR-68. FEASIBILITY STUDY OF THE EMULATE THERAPEUTICS™ VOYAGER SYSTEM IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM). (11th November 2019) Authors: Barkhoudarian, Garni; Badruddoja, Michael; Blondin, Nicholas; Chen, Ricky; Chowdhary, Sajeel; Cobbs, Charles; Dowling, Anthony; Duic, Paul; Paul Flores, John; Fonkem, Ekokobe; McClay, Edward; Nabors, Louis; Salacz, Michael; Vaillant, Brian; Kesari, Santosh Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CTIM-11. PHASE 2 STUDY OF SL-701, A NOVEL IMMUNOTHERAPY, IN ADULTS WITH RECURRENT GBM: A HIGH PARAMETER FLOW CYTOMETRY ANALYSIS OF CD8+ T CELLS AND POTENTIAL IMPLICATIONS FOR PATIENT ENRICHMENT STRATEGIES. (12th November 2021) Authors: Peereboom, David; Lindsay, Ross; Badruddoja, Michael; Nabors, L Burt; Kumthekar, Priya; Lieberman, Frank; Tran, David; Phuphanich, Surasak; Schiff, David; Sherman, Jonathan; Butowski, Nicholas; Dunbar, Erin; Fink, Karen; Iwamoto, Fabio; Moertel, Christopher; Schulder, Michael; Walbert, Tobias; Ha... Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CTIM-29. PHASE 2 STUDY OF A NOVEL IMMUNOTHERAPY SL-701 IN ADULTS WITH RECURRENT GBM: IDENTIFICATION OF TREATMENT-INDUCED CD8+CD107A+ CD57+ PD-1- MEMORY T-CELLS THAT ARE ASSOCIATED WITH INCREASED SURVIVAL. (14th November 2022) Authors: Peereboom, David; Lindsay, Ross; Badruddoja, Michael; Nabors, L Burt; Kumthekar, Priya; Lieberman, Frank; Tran, David; Phuphanich, Surasak; Schiff, David; Sherman, Jonathan; Butowski, Nicholas; Dunbar, Erin; Fink, Karen; Iwamoto, Fabio; Moertel, Christopher; Schulder, Michael; Walbert, Tobias; Ha... Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. CTNI-38. PAMIPARIB IN COMBINATION WITH RADIATION THERAPY (RT) AND/OR TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED (ND) OR RECURRENT/REFRACTORY (R/R) GLIOBLASTOMA (GBM); PHASE 1B/2 STUDY UPDATE. (9th November 2020) Authors: Piotrowski, Anna; Puduvalli, Vinay; Wen, Patrick; Colman, Howard; Campian, Jian; Pearlman, Michael; Butowski, Nicholas; Cloughesy, Timothy; Battiste, James; Glass, Jon; Schiff, David; van den Bent, Martin; Walbert, Tobias; Ahluwalia, Manmeet; Badruddoja, Michael; Kalra, Amandeep; Pelham, Robert; ... Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗